SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spyre Therapeutics, Inc. – SYRE
Pomerantz LLP is investigating claims on behalf of investors of Spyre Therapeutics, Inc. (“Spyre” or the “Company”)(NASDAQ: SYRE). Such investors are advised to contact DaniellePeyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Spyre and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for […]